Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PRECISION BIOSCIENCES INC Director's Dealing 2022

May 31, 2022

34491_dirs_2022-05-31_fd265166-caca-4a14-8daa-7bf5774ca23d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PRECISION BIOSCIENCES INC (DTIL)
CIK: 0001357874
Period of Report: 2022-05-26

Reporting Person: Brown Melinda (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2022-05-26 Stock Option (Right to Buy) $1.55 A 376683 Acquired 2032-05-25 Common Stock (376683) Direct

Footnotes

F1: The option vests in 36 substantially equal monthly installments following May 26, 2022, such that the option shall be fully vested on May 26, 2025, subject to the Reporting Person's continued service to the Issuer through the applicable vesting date.